917
Views
16
CrossRef citations to date
0
Altmetric
Research Papers

Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection

, , , , , & show all
Pages 438-450 | Received 29 Apr 2015, Accepted 24 Jul 2015, Published online: 23 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kathryn M. Jones, Cristina Poveda, Leroy Versteeg, Maria Elena Bottazzi & Peter J. Hotez. (2022) Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine. Expert Review of Vaccines 21:9, pages 1185-1203.
Read now
Subhadip Choudhuri, Lizette Rios, Juan Carlos Vázquez-Chagoyán & Nisha Jain Garg. (2021) Oxidative stress implications for therapeutic vaccine development against Chagas disease. Expert Review of Vaccines 20:11, pages 1395-1406.
Read now
Abel Ramos-Vega, Elizabeth Monreal-Escalante, Eric Dumonteil, Bernardo Bañuelos-Hernández & Carlos Angulo. (2021) Plant-made vaccines against parasites: bioinspired perspectives to fight against Chagas disease. Expert Review of Vaccines 20:11, pages 1373-1388.
Read now

Articles from other publishers (13)

Luciana L. Soprano, Maximiliano R. Ferrero, Thomas Jacobs, Alicia S. Couto & Vilma G. Duschak. (2023) Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Luísa M D Magalhães, Kenneth J Gollob, Bianca Zingales & Walderez O Dutra. (2022) Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions. The Lancet Microbe 3:9, pages e711-e722.
Crossref
Luciana L. Soprano, Maximiliano R. Ferrero, Malena Landoni, Gabriela A. García, Mónica I. Esteva, Alicia S. Couto & Vilma G. Duschak. (2022) Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Eric Dumonteil & Claudia Herrera. (2021) The Case for the Development of a Chagas Disease Vaccine: Why? How? When?. Tropical Medicine and Infectious Disease 6:1, pages 16.
Crossref
Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, Neelakshi Mungra, Maryam Karaan, Krupa Naran & Stefan Barth. (2021) Recent advances in immunotherapies against infectious diseases. Immunotherapy Advances 1:1.
Crossref
Lucas D. Caeiro, Yamil E. Masip, Mariana Rizzi, Matías E. Rodríguez, Celeste Pueblas Castro, Daniel O. Sánchez, M. Lorena Coria, Juliana Cassataro & Valeria Tekiel. (2020) The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice. Vaccine 38:48, pages 7645-7653.
Crossref
Natacha Cerny, Augusto Ernesto Bivona, Andrés Sanchez Alberti, Sebastián Nicolás Trinitario, Celina Morales, Alejandro Cardoso Landaburu, Silvia Inés Cazorla & Emilio Luis Malchiodi. (2020) Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi. Frontiers in Immunology 11.
Crossref
Minerva Arce-Fonseca, Ana C. Carbajal-Hernández, Mónica Lozano-Camacho, Silvia del C. Carrillo-Sánchez, Francisco-Javier Roldán, Alberto Aranda-Fraustro, José Luis Rosales-Encina & Olivia Rodríguez-Morales. (2020) DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi . Journal of Immunology Research 2020, pages 1-18.
Crossref
Augusto E. Bivona, Andrés Sánchez Alberti, Natacha Cerny, Sebastián N. Trinitario & Emilio L. Malchiodi. (2020) Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:5, pages 165658.
Crossref
María José Ferrer, Diana Patricia Wehrendt, Mariana Bonilla, Marcelo Alberto Comini, María Teresa Tellez-Iñón & Mariana Potenza. 2019. T. cruzi Infection. T. cruzi Infection 105 118 .
Augusto E. Bivona, Andrés Sánchez Alberti, Marina N. Matos, Natacha Cerny, Alejandro C. Cardoso, Celina Morales, Germán González, Silvia I. Cazorla & Emilio L. Malchiodi. (2018) Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine. PLOS Neglected Tropical Diseases 12:3, pages e0006384.
Crossref
Estefanía Prochetto, Carolina Roldán, Iván A. Bontempi, Daiana Bertona, Luz Peverengo, Miguel H. Vicco, Luz M. Rodeles, Ana R. Pérez, Iván S. Marcipar & Gabriel Cabrera. (2017) Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype . Oncotarget 8:35, pages 58003-58020.
Crossref
Gonzalo R. Acevedo, Silvia A. Longhi, Alcinette Bunying, Nazila Sabri, Augusto Atienza, María P. Zago, Radleigh Santos, Valeria A. Judkowski, Clemencia Pinilla & Karina A. Gómez. (2017) Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients. PLOS ONE 12:5, pages e0178380.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.